RAS blockers shift the balance to increase circulating levels of Ang-(1–7), this may contribute to shunt the ACE/Ang II/AT1 pathway toward the ACE2/Ang-(1–7)/MasR pathway providing beneficial effects on mood disorders (17). Here, AGTR1 is linked to mood disorder.